BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34810275)

  • 1. Predictors and clinical outcomes of poor symptomatic improvement after transcatheter aortic valve replacement.
    Yoshijima N; Saito T; Inohara T; Anzai A; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
    Open Heart; 2021 Nov; 8(2):. PubMed ID: 34810275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of severe aortic stenosis patients combined with diabetes mellitus after transcatheter aortic valve replacement and short-term outcome.
    Su W; Tai S; Huang Y; Hu X; Zhou S; Fang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):309-318. PubMed ID: 35545323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants and Impact of Heart Failure Readmission Following Transcatheter Aortic Valve Replacement.
    Auffret V; Bakhti A; Leurent G; Bedossa M; Tomasi J; Belhaj Soulami R; Verhoye JP; Donal E; Galli E; Loirat A; Sharobeem S; Sost G; Le Guellec M; Boulmier D; Le Breton H
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008959. PubMed ID: 32600108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, predictors, and prognostic significance of impaired functional status early after transcatheter aortic valve replacement.
    Nuche J; Ternacle J; Avvedimento M; Cheema AN; Veiga-Fernández G; Muñoz-García AJ; Vilalta V; Regueiro A; Asmarats L; Del Trigo M; Serra V; Bonnet G; Jonveaux M; Esposito G; Rezaei E; de la Torre-Hernández JM; Fernández-Nofrerías E; Vidal P; Gutiérrez-Alonso L; Oteo JF; Belahnech Y; Mohammadi S; Philippon F; Modine T; Mesnier J; Rodés-Cabau J
    Rev Esp Cardiol (Engl Ed); 2024 May; 77(5):396-407. PubMed ID: 38000627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' characteristics and mortality in urgent/emergent/salvage transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry.
    Enta Y; Miyasaka M; Taguri M; Tada N; Hata M; Watanabe Y; Naganuma T; Yamawaki M; Yamanaka F; Shirai S; Ueno H; Mizutani K; Tabata M; Takagi K; Yamamoto M; Hayashida K;
    Open Heart; 2020 Dec; 7(2):. PubMed ID: 33318151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.
    Kindya B; Ouzan E; Lerakis S; Gonen E; Babaliaros V; Karayel E; Thourani VH; Gotsman I; Devireddy CM; Danenberg HD; Leshnower BG; Beeri R; Ko YA; Gilon D; Ahmed H; Liu C; Lotan C; Mavromatis K
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):574-582. PubMed ID: 29602220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of moderate to severe mitral stenosis in patients undergoing transcatheter aortic valve replacement.
    Fischer Q; Himbert D; Bernier M; Urena M; Nunes Ferreira-Neto A; Paradis JM; Mohammadi S; Iung B; Rodés-Cabau J
    Int J Cardiol; 2019 Jul; 286():36-42. PubMed ID: 30967274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.
    Freitas-Ferraz AB; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Annabi MS; Pelletier-Beaumont E; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2020 Mar; 13(5):567-579. PubMed ID: 32061600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study.
    Bleiziffer S; Bosmans J; Brecker S; Gerckens U; Wenaweser P; Tamburino C; Linke A;
    Clin Res Cardiol; 2017 Oct; 106(10):784-795. PubMed ID: 28484830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, Prognostic Impact, and Predictive Factors of Readmission for Heart Failure After Transcatheter Aortic Valve Replacement.
    Durand E; Doutriaux M; Bettinger N; Tron C; Fauvel C; Bauer F; Dacher JN; Bouhzam N; Litzler PY; Cribier A; Eltchaninoff H
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2426-2436. PubMed ID: 29217006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry.
    Arnold SV; Spertus JA; Vemulapalli S; Li Z; Matsouaka RA; Baron SJ; Vora AN; Mack MJ; Reynolds MR; Rumsfeld JS; Cohen DJ
    JAMA Cardiol; 2017 Apr; 2(4):409-416. PubMed ID: 28146260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and Risk Calculator of Early Unplanned Hospital Readmission Following Contemporary Self-Expanding Transcatheter Aortic Valve Replacement from the STS/ACC TVT Registry.
    Sanchez CE; Hermiller JB; Pinto DS; Chetcuti SJ; Arshi A; Forrest JK; Huang J; Yakubov SJ
    Cardiovasc Revasc Med; 2020 Mar; 21(3):263-270. PubMed ID: 31255552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
    Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
    J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate and long-term prognostic implications of mitral regurgitation in patients undergoing transcatheter aortic valve replacement.
    Abdelghani M; Abdel-Wahab M; Hemetsberger R; Landt M; Merten C; Toelg R; Richardt G
    Int J Cardiol; 2019 Aug; 288():39-43. PubMed ID: 30948219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter Treatment of Residual Significant Mitral Regurgitation Following TAVR: A Multicenter Registry.
    Witberg G; Codner P; Landes U; Barbanti M; Valvo R; De Backer O; Ooms JF; Sievert K; El Sabbagh A; Jimenez-Quevedo P; Brennan PF; Sedaghat A; Masiero G; Werner P; Overtchouk P; Watanabe Y; Montorfano M; Bijjam VR; Hein M; Fiorina C; Arzamendi D; Rodriguez-Gabella T; Fernández-Vázquez F; Baz JA; Laperche C; Grasso C; Branca L; Estévez-Loureiro R; Benito-González T; Amat Santos IJ; Ruile P; Mylotte D; Buzzatti N; Piazza N; Andreas M; Tarantini G; Sinning JM; Spence MS; Nombela-Franco L; Guerrero M; Sievert H; Sondergaard L; Van Mieghem NM; Tchetche D; Webb JG; Kornowski R
    JACC Cardiovasc Interv; 2020 Dec; 13(23):2782-2791. PubMed ID: 33303117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends, Predictors, and Outcomes of 30-Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database.
    Zahid S; Din MTU; Khan MZ; Rai D; Ullah W; Sanchez-Nadales A; Elkhapery A; Khan MU; Goldsweig AM; Singla A; Fonarrow G; Balla S
    J Am Heart Assoc; 2022 Aug; 11(16):e024890. PubMed ID: 35929464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
    Goel K; Shah P; Jones BM; Korngold E; Bhardwaj A; Kar B; Barker C; Szerlip M; Smalling R; Dhoble A
    Eur Heart J; 2023 Sep; 44(33):3181-3195. PubMed ID: 37350747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Sabatino J; De Rosa S; Leo I; Strangio A; La Bella S; Sorrentino S; Mongiardo A; Spaccarotella C; Polimeni A; Indolfi C
    Open Heart; 2021 Jul; 8(2):. PubMed ID: 34233914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.